Paul E. Sackstein

Hematology

3800 Reservoir Rd NW
Washington, DC 20007

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.

Effectiveness and safety of immunotherapy in advanced NSCLC with pericardial effusions: a global retrospective multicenter study.

Journal: The oncologist

Published: February 16, 2026

How should we approach salvage therapy in advanced renal cell carcinoma after first-line immunotherapy combinations?

How should we approach salvage therapy in advanced renal cell carcinoma after first-line immunotherapy combinations?

Journal: Expert opinion on biological therapy

Published: January 27, 2025

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.

Safety and efficacy of immune checkpoint therapy for the treatment of patients with cardiac metastasis: a multicenter international retrospective study.

Journal: Journal for immunotherapy of cancer

Published: January 03, 2025

Ancestry-associated social and genomic hallmarks linked with inferior outcome in elderly acute myeloid leukemia.

Ancestry-associated social and genomic hallmarks linked with inferior outcome in elderly acute myeloid leukemia.

Journal: BMC cancer

Published: November 22, 2024

Evolving Standards of Care in the Management of Localized Colorectal Cancer.

Evolving Standards of Care in the Management of Localized Colorectal Cancer.

Journal: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting

Published: May 20, 2024

Transplant Eligible and Ineligible Elderly Patients with AML-A Genomic Approach and Next Generation Questions.

Transplant Eligible and Ineligible Elderly Patients with AML-A Genomic Approach and Next Generation Questions.

Journal: Biomedicines

Published: March 17, 2024

Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer.

Overcoming the hurdles: surmounting acquired resistance to anti-EGFR therapy in metastatic colorectal cancer.

Journal: Clinical advances in hematology & oncology : H&O

Published: November 10, 2023

Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis.

Use of Erdafitinib in FGFR3-Mutated Recurrent Respiratory Papillomatosis.

Journal: JCO precision oncology

Published: December 01, 2022

A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer.

A Multicenter Retrospective Chart Review of Clinical Outcomes Among Patients With KRAS G12C Mutant Non-Small Cell Lung Cancer.

Journal: Clinical lung cancer

Published: October 07, 2022

Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.

Race & sex disparities related to low-dose computed tomography lung cancer screening eligibility criteria: A lung cancer cases review.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: December 30, 2021

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.

Comprehensive Analysis of R-Spondin Fusions and RNF43 Mutations Implicate Novel Therapeutic Options in Colorectal Cancer.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: August 20, 2021

Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.

Pembrolizumab-induced cytokine release syndrome in a patient with metastatic lung adenocarcinoma: a case report.

Journal: Journal for immunotherapy of cancer

Published: May 27, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026